← FDA Drug Approvals (Drugs@FDA)
ARIPIPRAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMTAK INC · Approved 2018-12-26
Drug application
- FDA Application #
ANDA208260- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ARIPIPRAZOLE
- Generic name
- Aripiprazole
- Active ingredients
- ARIPIPRAZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- PHARMTAK INC
- First approval
- 2018-12-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown